LISA M. MANDRUSIAK is an associate in the firm's Litigation practice group. With a background in molecular biology and genetics, she has a deep understanding of the sciences and technologies involved in her clients' chemical, biochemical, biomedical and pharmaceutical inventions.

In addition to litigating cases in federal courts, Ms. Mandrusiak advises her clients on litigation procedure and strategies, litigation avoidance, and the overall protection, exploitation, and enforcement of global patent portfolios. Ms. Mandrusiak's experience with international patent laws and prosecution enables her to better understand and communicate with foreign clients when strategizing and explaining U.S. patent laws.

Prior to attending law school, Ms. Mandrusiak worked as a Patent Technology Specialist at Shusaku Yamamoto Patent Attorneys in Osaka, Japan where she prosecuted hundreds of patent applications in a variety of countries including Japan, Europe, and the United States and advised clients on successful strategies for managing international intellectual property portfolios. During law school, Ms. Mandrusiak worked as a contract associate at Verrill Dana, LLP in Portland, Maine prosecuting patents and advising on intellectual property litigation matters.

Professional Affiliations

American Bar Association

American Intellectual Property Law Association (AIPLA)

Pauline Newman Inn of Court

Accolades

ABA/BNA Award for Excellence in the Study of Intellectual Property Law (2011)

Wernick Prize for Legal Writing for the best legal scholarship submitted by a student (2011)

Resources

Publications

Will PTAB Decisions In Interferences Declared After September 15, 2012 Be Reviewable In Court?

Tuesday, December 18, 2012

'Discovering' Trade Secrets: The Devil is in the Details

Thursday, August 16, 2012

How Will Kappos v. Hyatt Impact 35 USC 146 Actions?

Wednesday, July 18, 2012

"Balancing Open Source Paradigms and Traditional Intellectual Property Models to Optimize Innovation," Maine Law Review, 2010, Vol. 63, page 303.

"Transglutaminase potentiates ligand-dependent proteasome dysfunction induced by polyglutamine-expanded androgen receptor," Human Molecular Genetics, 2003, Vol. 12, page 1497.

Blog

Status Quo: The Federal Circuit Affirms Gene Patentability In Myriad
Thursday, August 16, 2012
A 2-1 split panel of the Federal Circuit issued its decision today in the closely-watched Myriad case, Association for Molecular Pathology v. Myriad Genetics, Inc., __ F.3d __ (Fed. Cir. 2012) (Lourie, J.).